LYZ and inflammatory bowel disease: In addition to a number of genes that were found to be differentially expressed between the IBD and control samples (e.g., DEFA5, DEFA6, LYZ, PLA2G2A, CD40, and CD44), ileal IECs revealed CD-specific changes in gene expression when compared with either controls or UC.